This opening in Madrid strengthens Genomcore’s institutional presence and operational capacity in the nerve centre of the Spanish healthcare ecosystem. The company is already at the forefront of major initiatives, demonstrating its expertise and national reach.
Genomcore leads key projects such as SIGenES, the national genomic information exchange network for the National Health System, and DIPCAN, the most ambitious publicly funded artificial intelligence project in oncology in Spain. Furthermore, Genomcore BIMS serves as the technological foundation for strategic programs such as OMIQ-HES in Catalonia, Osagen in the Basque Country, and the Medigenomics initiative in the Community of Madrid, among others. These projects, combined, confirm Genomcore’s technology and expertise for charting the future course of personalized medicine.
The new offices are strategically located on the Paseo de la Castellana, in the heart of the Chamartín district. Genomcore thus integrates into the Madrid Health Hub, a key space that concentrates health innovation and talent.
The consolidation in Madrid is essential to the company’s strategy for continuing to lead the harmonization and secure exploitation of multimodal health data. Genomcore is positioned as the partner that facilitates responsible innovation and regulatory compliance for health systems, hospitals, corporations, and startups in the digital health sector, ensuring the maximum protection of data.
